Cellular Biomedicine Group Inc buy melinda
Start price
02.07.17
/
50%
€7.94
Target price
20.07.17
€8.79
Performance (%)
7.39%
End price
20.07.17
€8.52
Summary
This prediction ended on 20.07.17 with a price of €8.52. With a performance of 7.39%, the BUY prediction by melinda for Cellular Biomedicine Group Inc closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Cellular Biomedicine Group Inc | - | - | - | - |
iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
Comments by melinda for this prediction
In the thread Cellular Biomedicine Group Inc diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
$
(Vom Mitglied beendet)
Stopped prediction by melinda for Cellular Biomedicine Group Inc
Cellular Biomedicine Group Inc
Start price
Target price
Perf. (%)
€15.60
29.08.20
29.08.20
€13.00
04.11.21
04.11.21
3.85%
26.02.21
26.02.21
Cellular Biomedicine Group Inc
Start price
Target price
Perf. (%)
€14.68
11.05.19
11.05.19
€16.24
29.08.20
29.08.20
6.23%
29.08.20
29.08.20
Cellular Biomedicine Group Inc
Start price
Target price
Perf. (%)
€13.87
18.10.18
18.10.18
€17.14
08.11.18
08.11.18
13.00%
08.11.18
08.11.18
Cellular Biomedicine Group Inc
Start price
Target price
Perf. (%)
€18.04
17.09.18
17.09.18
€19.39
21.09.18
21.09.18
8.75%
21.09.18
21.09.18
Cellular Biomedicine Group Inc
Start price
Target price
Perf. (%)
€8.80
02.07.17
02.07.17
€9.75
20.07.17
20.07.17
7.39%
20.07.17
20.07.17